Zoumpourlis V - Search Results

1

miRNA-Based Technologies in Cancer Therapy.

Pagoni M, Cava C, Sideris DC, Avgeris M, Zoumpourlis V, Michalopoulos I, Drakoulis N. Pagoni M, et al. Among authors: zoumpourlis v. J Pers Med. 2023 Nov 9;13(11):1586. doi: 10.3390/jpm13111586. J Pers Med. 2023. PMID: 38003902 Free PMC article. Review.

2

Non-coding RNAs (miRNAs and lncRNAs) and their roles in lymphogenesis in all types of lymphomas and lymphoid malignancies.

Drillis G, Goulielmaki M, Spandidos DA, Aggelaki S, Zoumpourlis V. Drillis G, et al. Among authors: zoumpourlis v. Oncol Lett. 2021 May;21(5):393. doi: 10.3892/ol.2021.12654. Epub 2021 Mar 18. Oncol Lett. 2021. PMID: 33777216 Free PMC article. Review.

3

Historical retrospective of the SRC oncogene and new perspectives (Review).

Simatou A, Simatos G, Goulielmaki M, Spandidos DA, Baliou S, Zoumpourlis V. Simatou A, et al. Among authors: zoumpourlis v. Mol Clin Oncol. 2020 Oct;13(4):21. doi: 10.3892/mco.2020.2091. Epub 2020 Jul 14. Mol Clin Oncol. 2020. PMID: 32765869 Free PMC article. Review.

4

Prostate Cancer Biomarkers: From diagnosis to prognosis and precision-guided therapeutics.

Adamaki M, Zoumpourlis V. Adamaki M, et al. Among authors: zoumpourlis v. Pharmacol Ther. 2021 Dec;228:107932. doi: 10.1016/j.pharmthera.2021.107932. Epub 2021 Jun 24. Pharmacol Ther. 2021. PMID: 34174272 Review.

5

The impact of radiation therapy on the TCR Vβ chain repertoire in patients with prostate cancer.

Goulielmaki M, Davanos N, Kogionou P, Batsaki P, Stokidis S, Adamaki M, Mosa E, Vasilakou E, Zambatis C, Gritzapis AD, Zoumpourlis V, Baxevanis CN, Fortis SP. Goulielmaki M, et al. Among authors: zoumpourlis v. Int J Oncol. 2022 Jun;60(6):71. doi: 10.3892/ijo.2022.5361. Epub 2022 Apr 21. Int J Oncol. 2022. PMID: 35445738 Free PMC article.

6

T-Cell Repertoire in Tumor Radiation: The Emerging Frontier as a Radiotherapy Biomarker.

Baxevanis CN, Gritzapis AD, Voutsas IF, Batsaki P, Goulielmaki M, Adamaki M, Zoumpourlis V, Fortis SP. Baxevanis CN, et al. Among authors: zoumpourlis v. Cancers (Basel). 2022 May 27;14(11):2674. doi: 10.3390/cancers14112674. Cancers (Basel). 2022. PMID: 35681654 Free PMC article. Review.

7

Let-7, mir-98 and mir-183 as biomarkers for cancer and schizophrenia [corrected].

Rizos E, Siafakas N, Katsantoni E, Skourti E, Salpeas V, Rizos I, Tsoporis JN, Kastania A, Filippopoulou A, Xiros N, Margaritis D, Parker TG, Papageorgiou C, Zoumpourlis V. Rizos E, et al. Among authors: zoumpourlis v. PLoS One. 2015 Apr 9;10(4):e0123522. doi: 10.1371/journal.pone.0123522. eCollection 2015. PLoS One. 2015. PMID: 25856466 Free PMC article.

8

Immunotherapy as a Precision Medicine Tool for the Treatment of Prostate Cancer.

Adamaki M, Zoumpourlis V. Adamaki M, et al. Among authors: zoumpourlis v. Cancers (Basel). 2021 Jan 6;13(2):173. doi: 10.3390/cancers13020173. Cancers (Basel). 2021. PMID: 33419051 Free PMC article. Review.

9

Role of taurine, its haloamines and its lncRNA TUG1 in both inflammation and cancer progression. On the road to therapeutics? (Review).

Baliou S, Kyriakopoulos AM, Spandidos DA, Zoumpourlis V. Baliou S, et al. Among authors: zoumpourlis v. Int J Oncol. 2020 Sep;57(3):631-664. doi: 10.3892/ijo.2020.5100. Epub 2020 Jul 14. Int J Oncol. 2020. PMID: 32705269 Free PMC article. Review.

10

[Comment] The COVID‑19 pandemic as a scientific and social challenge in the 21st century.

Zoumpourlis V, Goulielmaki M, Rizos E, Baliou S, Spandidos DA. Zoumpourlis V, et al. Mol Med Rep. 2020 Oct;22(4):3035-3048. doi: 10.3892/mmr.2020.11393. Epub 2020 Jul 30. Mol Med Rep. 2020. PMID: 32945405 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

125 results

Search Page